Tianshui Zhongxing Bio-technology Co Ltd (002772) — Working Capital to Net Assets Ratio
Tianshui Zhongxing Bio-technology Co Ltd (002772) has a Working Capital to Net Assets ratio of 44.9% as of September 2025. Working capital of CN¥1.53 Billion (current assets of CN¥2.95 Billion minus current liabilities of CN¥1.43 Billion) is measured against net assets of CN¥3.40 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Tianshui Zhongxing Bio-technology Co Ltd to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tianshui Zhongxing Bio-technology Co Ltd Working Capital to Net Assets (2011–2024)
This chart shows how Tianshui Zhongxing Bio-technology Co Ltd's Working Capital to Net Assets ratio has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the ratio stands at 44.9%, reflecting working capital of CN¥1.53 Billion against net assets of CN¥3.40 Billion CNY. For the complete balance sheet picture, see Tianshui Zhongxing Bio-technology Co Ltd total assets.
Annual Working Capital to Net Assets for Tianshui Zhongxing Bio-technology Co Ltd (2011–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tianshui Zhongxing Bio-technology Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Tianshui Zhongxing Bio-technology Co Ltd to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 33.6% | CN¥1.12 Billion | CN¥3.32 Billion | CN¥2.83 Billion | CN¥1.71 Billion | ▼ -1.3 pp |
| 2023 | 34.9% | CN¥1.20 Billion | CN¥3.44 Billion | CN¥2.66 Billion | CN¥1.46 Billion | ▼ -12.2 pp |
| 2022 | 47.1% | CN¥1.59 Billion | CN¥3.38 Billion | CN¥3.04 Billion | CN¥1.44 Billion | ▼ -22.4 pp |
| 2021 | 69.5% | CN¥2.26 Billion | CN¥3.25 Billion | CN¥3.08 Billion | CN¥819.53 Million | ▲ +19.6 pp |
| 2020 | 49.8% | CN¥1.36 Billion | CN¥2.73 Billion | CN¥2.22 Billion | CN¥853.69 Million | ▼ -4.6 pp |
| 2019 | 54.4% | CN¥1.42 Billion | CN¥2.60 Billion | CN¥1.82 Billion | CN¥404.23 Million | ▲ +14.7 pp |
| 2018 | 39.7% | CN¥1.05 Billion | CN¥2.63 Billion | CN¥1.37 Billion | CN¥326.87 Million | ▼ -22.7 pp |
| 2017 | 62.4% | CN¥1.64 Billion | CN¥2.63 Billion | CN¥1.95 Billion | CN¥308.16 Million | ▲ +9.7 pp |
| 2016 | 52.7% | CN¥1.21 Billion | CN¥2.29 Billion | CN¥1.57 Billion | CN¥361.77 Million | ▲ +28.2 pp |
| 2015 | 24.5% | CN¥254.46 Million | CN¥1.04 Billion | CN¥531.36 Million | CN¥276.91 Million | ▼ -18.1 pp |
| 2014 | 42.6% | CN¥212.02 Million | CN¥498.05 Million | CN¥331.86 Million | CN¥119.84 Million | ▲ +5.5 pp |
| 2013 | 37.1% | CN¥151.14 Million | CN¥407.25 Million | CN¥209.09 Million | CN¥57.95 Million | ▲ +16.9 pp |
| 2012 | 20.2% | CN¥71.11 Million | CN¥351.30 Million | CN¥125.48 Million | CN¥54.37 Million | ▲ +5.8 pp |
| 2011 | 14.4% | CN¥26.20 Million | CN¥181.49 Million | CN¥77.59 Million | CN¥51.39 Million | — |